Expert Commentary

What to do about the problem of non-FDA approved compounded bioidentical hormones

OBG Manag. 2017 October;29(10)
By
Cynthia Stuenkel, MD
Author and Disclosure Information

How does Dr. Stuenkel recommend the problem of increased compounded hormone therapy use be addressed?

 

Click here to download

Recommended Reading

Syphilis rates reach record high
MDedge ObGyn
Should we stop administering the influenza vaccine to pregnant women?
MDedge ObGyn
Trump administration narrows contraceptive mandate
MDedge ObGyn
Duty vs. confidentiality
MDedge ObGyn
MACRA Monday: Try this measure
MDedge ObGyn
Gap in osteoporosis diagnosis and treatment stirs concern
MDedge ObGyn
Tdap during pregnancy, or before, offers infants pertussis protection
MDedge ObGyn
Contraception coverage rollback is discriminatory
MDedge ObGyn
Nearly 80% of health care personnel stepped up for flu shots
MDedge ObGyn
Hyperlipidemia diagnosis protects against breast cancer
MDedge ObGyn